BR0111428A - Combinações de eter carboxialquìlico e inibidor de acat - Google Patents

Combinações de eter carboxialquìlico e inibidor de acat

Info

Publication number
BR0111428A
BR0111428A BR0111428-0A BR0111428A BR0111428A BR 0111428 A BR0111428 A BR 0111428A BR 0111428 A BR0111428 A BR 0111428A BR 0111428 A BR0111428 A BR 0111428A
Authority
BR
Brazil
Prior art keywords
acat inhibitor
combinations
ether
carboxyalkyl
formula
Prior art date
Application number
BR0111428-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Bruce Jeffrey Auerbach
Donna Lee Zobel
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0111428A publication Critical patent/BR0111428A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR0111428-0A 2000-06-07 2001-05-08 Combinações de eter carboxialquìlico e inibidor de acat BR0111428A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21005600P 2000-06-07 2000-06-07
PCT/US2001/014804 WO2001093845A2 (en) 2000-06-07 2001-05-08 Carboxyalkylether-acat inhibitor combinations

Publications (1)

Publication Number Publication Date
BR0111428A true BR0111428A (pt) 2003-06-10

Family

ID=22781424

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111428-0A BR0111428A (pt) 2000-06-07 2001-05-08 Combinações de eter carboxialquìlico e inibidor de acat

Country Status (14)

Country Link
EP (1) EP1292363A2 (es)
JP (1) JP2003535125A (es)
AR (1) AR034255A1 (es)
AU (1) AU2001263003A1 (es)
BR (1) BR0111428A (es)
CA (1) CA2413906A1 (es)
GT (1) GT200100106A (es)
MX (1) MXPA02010762A (es)
PA (1) PA8518601A1 (es)
PE (1) PE20020265A1 (es)
SV (1) SV2002000466A (es)
TN (1) TNSN01085A1 (es)
UY (1) UY26752A1 (es)
WO (1) WO2001093845A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387236B2 (en) 2001-10-09 2008-06-17 Delaware Capital Formation, Inc. Dispensing of currency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE320803T1 (de) * 1998-01-28 2006-04-15 Warner Lambert Co Verfahren zur behandlung von alzheimerschen krankheit

Also Published As

Publication number Publication date
EP1292363A2 (en) 2003-03-19
JP2003535125A (ja) 2003-11-25
SV2002000466A (es) 2002-04-03
MXPA02010762A (es) 2003-03-10
TNSN01085A1 (en) 2005-11-10
WO2001093845A2 (en) 2001-12-13
CA2413906A1 (en) 2001-12-13
AR034255A1 (es) 2004-02-18
GT200100106A (es) 2002-05-20
WO2001093845A3 (en) 2002-10-10
UY26752A1 (es) 2001-07-31
PE20020265A1 (es) 2002-04-19
AU2001263003A1 (en) 2001-12-17
PA8518601A1 (es) 2002-07-30

Similar Documents

Publication Publication Date Title
BG105428A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
MY121405A (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
EP1163208A4 (en) CASPASE INHIBITORS AND THEIR USE
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
BR0209064A (pt) Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células
MX2007004783A (es) Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
EA200200858A1 (ru) Фармацевтические композиции, содержащие ингибиторы гликогенфосфорилазы
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
MA29746B1 (fr) Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l'hepatite c
ES2193874A1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
YU18999A (sh) Supstituisani tricikli
BRPI0408897A (pt) derivados de 1,2,3,4-tetrahidro-e 1,2-dihidro-quinolina 1,2,4-substituìdos como inibidores de cetp para o tratamento de arteroesclerose e obesidade
MA30272B1 (fr) Derives de dibenzylamines servant d'inhibiteurs de cetp.
MX2007003441A (es) Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4- tetrahidroquinolina.
BR0111428A (pt) Combinações de eter carboxialquìlico e inibidor de acat
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
BR0309009A (pt) Método para o tratamento de hipersecreção de muco
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
ATE198323T1 (de) Diphenylstibene als prodrugs zu cox-2-inhibitoren
PT1292290E (pt) Composicoes farmaceuticas que compreendem derivados de acriloil-distamicina e inibidores de topoisomerase 1 e ii
IL113706A (en) N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them
DK0966462T3 (da) Heterocykliske forbindelser, der er egnede som oxidosqualencyklaseinhibitorer
BR0211425A (pt) Método para a preparação de compostos, e, uso de uma composição
BR0214241A (pt) Método para preparar uma composição compreendendo lipossomas contendo anestésico tópico e composição obtida
BR0107204A (pt) Inibidores da angiogênese de hidrazida e alcoxiamida

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.